Roche in the news

Zealand Pharma says obesity drug deal with Roche will help it stay independent

Read on: Financial Times

Roche to invest $50 billion in US to avoid Trump tariffs

Read on: Daily Sabah

Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit

Read on: CNBC News

Roche to spend $50bn on US manufacturing and RD

Read on: Financial Times

'Roche could've earned over 100 times what it cost for rare disease drug'

Read on: Times of India

Swiss pharmaceuticals company Roche announces $50B investment in U.S. over next 5 years

Read on: The Washington Times

Roche to invest $50 billion in the U.S. as pharma tariff threat lingers

Read on: CNBC News

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Read on: The Guardian

Roche to Invest $50 Billion in Pharma, Diagnostics in US.com

Read on: Bloomberg

Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

Read on: CNBC News

Roche agrees biggest-ever obesity drug deal

Read on: Financial Times

Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today

Read on: Quartz

Roche shares pop 5% on $5.3 billion obesity drug deal with Zealand Pharma

Read on: CNBC News

Roche goes beyond diagnostics innovation and builds partnerships for proactive healthcare

Read on: SCMP

Roche descendant Andre Hoffmann on pharma, feuds and family business

Read on: Financial Times

Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study

Read on: The Wall Street Journal

Roche Increases Dividend on Higher Sales

Read on: The Wall Street Journal

Roche plans to launch drugs and slash development costs

Read on: Financial Times

New weight loss drugs could be developed much faster if Roche gets its way

Read on: Quartz